Torsdag 7 Maj | 22:41:10 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2027-03-05 08:00 Bokslutskommuniké 2026
2026-11-28 08:00 Kvartalsrapport 2026-Q3
2026-08-28 08:00 Kvartalsrapport 2026-Q2
2026-05-29 08:00 Kvartalsrapport 2026-Q1
2026-05-22 N/A X-dag ordinarie utdelning OPTI 0.00 SEK
2026-05-21 N/A Årsstämma
2026-03-27 - Bokslutskommuniké 2025
2025-12-18 - Extra Bolagsstämma 2025
2025-11-27 - Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-05-29 - Kvartalsrapport 2025-Q1
2025-05-23 - X-dag ordinarie utdelning OPTI 0.00 SEK
2025-05-22 - Årsstämma
2025-03-28 - Bokslutskommuniké 2024
2024-11-06 - Extra Bolagsstämma 2024
2024-10-18 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-31 - Kvartalsrapport 2024-Q1
2024-05-23 - Årsstämma
2024-05-17 - X-dag ordinarie utdelning OPTI 0.00 SEK
2024-03-28 - Bokslutskommuniké 2023
2024-02-27 - Bokslutskommuniké 2023
2023-11-28 - Kvartalsrapport 2023-Q3
2023-10-05 - Extra Bolagsstämma 2023
2023-08-29 - Kvartalsrapport 2023-Q2
2023-05-05 - Kvartalsrapport 2023-Q1
2023-03-09 - X-dag ordinarie utdelning OPTI 0.00 SEK
2023-03-08 - Årsstämma
2023-02-14 - Bokslutskommuniké 2022
2022-11-23 - Extra Bolagsstämma 2022
2022-11-15 - Kvartalsrapport 2022-Q3
2022-08-16 - Kvartalsrapport 2022-Q2
2022-05-27 - X-dag ordinarie utdelning OPTI 0.00 SEK
2022-05-25 - Årsstämma
2022-05-06 - Kvartalsrapport 2022-Q1
2022-02-09 - Bokslutskommuniké 2021
2021-11-16 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-06-28 - Årsstämma
2021-05-28 - Kvartalsrapport 2021-Q1
2021-05-14 - X-dag ordinarie utdelning OPTI 0.00 SEK
2021-03-05 - Extra Bolagsstämma 2021
2021-02-16 - Bokslutskommuniké 2020
2020-11-06 - Kvartalsrapport 2020-Q3
2020-08-18 - Kvartalsrapport 2020-Q2
2020-05-15 - X-dag ordinarie utdelning OPTI 0.00 SEK
2020-05-14 - Årsstämma
2020-05-05 - Kvartalsrapport 2020-Q1
2020-02-14 - Bokslutskommuniké 2019
2019-11-28 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-08-22 - Extra Bolagsstämma 2019
2019-05-23 - Kvartalsrapport 2019-Q1
2019-04-12 - X-dag ordinarie utdelning OPTI 0.00 SEK
2019-04-11 - Årsstämma
2019-02-14 - Bokslutskommuniké 2018
2018-11-29 - Kvartalsrapport 2018-Q3
2018-08-29 - Kvartalsrapport 2018-Q2
2018-05-24 - Kvartalsrapport 2018-Q1
2018-04-25 - X-dag ordinarie utdelning OPTI 0.00 SEK
2018-04-24 - Årsstämma
2018-02-15 - Bokslutskommuniké 2017
2017-11-29 - Kvartalsrapport 2017-Q3
2017-08-29 - Kvartalsrapport 2017-Q2
2017-05-30 - Kvartalsrapport 2017-Q1
2017-03-15 - X-dag ordinarie utdelning OPTI 0.00 SEK
2017-03-14 - Årsstämma
2017-02-17 - Bokslutskommuniké 2016
2016-11-24 - Kvartalsrapport 2016-Q3
2016-08-26 - Kvartalsrapport 2016-Q2
2016-05-26 - Kvartalsrapport 2016-Q1
2016-04-29 - X-dag ordinarie utdelning OPTI 0.00 SEK
2016-04-26 - Årsstämma
2016-02-25 - Bokslutskommuniké 2015
2015-11-26 - Kvartalsrapport 2015-Q3
2015-08-27 - Kvartalsrapport 2015-Q2
2015-05-28 - Kvartalsrapport 2015-Q1
2015-04-29 - X-dag ordinarie utdelning OPTI 0.00 SEK
2015-04-28 - Årsstämma
2015-02-26 - Bokslutskommuniké 2014
2014-11-26 - Kvartalsrapport 2014-Q3
2014-11-17 - Extra Bolagsstämma 2014
2014-08-29 - Kvartalsrapport 2014-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorMaterial
IndustriForskning & Utveckling
OptiCept Technologies förser livsmedels-och växtindustrin med teknologiska lösningar som används för att öka hållbarheten för diverse råvaror. Bolaget arbetar med biologiska processer som ger en ökad extraktion ur råvaran, minskat avfall samt bibehållen smak, doft, färg, näringsinnehåll. Bolaget har en patenterad teknologi inom PEF (pulsed electric field) och VI (Vacuum Infusion). Bolaget säljer sina produkter på en global nivå. Huvudkontoret ligger i Lund.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-05-06 09:15:00

A total of approximately SEK 21 million has been received by OptiCept through payments from FPS regarding license fees and acquisition of inventory in accordance with the agreement. As part of this transaction, one loan to FPS of approximately SEK 7 million, have been repaid through a set-off.

The license payment of SEK 7 million for Q2 2026 has been invoiced according to agreement and received by OptiCept. In addition, payment of approximately SEK 14 million regarding inventory has also been invoiced and received. The revenue will be reported in Q2 2026.

The loan that FPS granted to OptiCept in the second quarter of 2025 has now been repaid in full. Including accrued interest, the loan at the time of repayment amounted to approximately SEK 7 million, OptiCept has received approximately SEK 14 million net.

The work of adapting OptiCept to a focused development company is progressing at a high pace. The cost-cutting measures that have been decided has been initiated and in majority implemented, which is expected to contribute to the company achieving positive results in the second half of 2026, in line with previous communication.

The implementation of the agreement with FPS is ongoing in parallel, and the handover of tasks is now taking place at a high pace. The focus is on ensuring that customer contacts and upcoming orders are handled in a professional manner with the support of sales staff from OptiCept and FPS. A number of OptiCept's key employees will also be offered roles within the FPS organization.

"This agreement with FPS is a milestone for OptiCept. By combining our technological innovation with FPS's market presence and resources, we create a strong platform for the future. For us, this is a way to become more efficient and focused; We retain the entire upside, but have significantly reduced the operational risk and downside in our business model. It feels great that we are now taking the next step in our journey towards a more efficient and profitable development company." Says Henrik Nettersand, Acting CEO